Loading…
Wednesday May 13, 2026 10:25am - 10:50am EDT
Lipid-based emulsions are increasingly used to enhance drug delivery, yet the impact of lipid digestion on permeation outcomes is often overlooked. This session examines how enzymatic digestion transforms emulsions into dynamic colloidal structures—such as mixed micelles and vesicles—that directly influence drug solubilization and transport across biological barriers. We will discuss why conventional in-vitro permeation models, when applied without accounting for digestion processes, may fail to predict in-vivo performance. Key factors including lipid composition, droplet size, bile interactions, and digestion kinetics will be highlighted. Attendees will gain practical insight into designing more biorelevant in-vitro permeation models that better reflect physiological conditions and support informed formulation development.
Speakers
avatar for Shabbir Lobo, PhD

Shabbir Lobo, PhD

Staff Scientist, Global Innovations and Product Development, Bayer
Shabbir is a skilled formulator in Transdermals, Modified Release oral Dosages and Topicals for Abbreviated New Drug Application (ANDA) and 505 b2 submissions. Attuned to current FDA regulations for a QbD based product development. dFMEA through the development of dosage form and... Read More →
Wednesday May 13, 2026 10:25am - 10:50am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link